{"id":8414,"date":"2021-03-30T11:07:59","date_gmt":"2021-03-30T00:07:59","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=8414"},"modified":"2021-03-30T11:07:59","modified_gmt":"2021-03-30T00:07:59","slug":"atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","title":{"rendered":"ATAGI- H\u01b0\u1edbng d\u1eabn v\u1eafc xin COVID-19 cho b\u1ec7nh nh\u00e2n suy gi\u1ea3m mi\u1ec5n d\u1ecbch"},"content":{"rendered":"<p>ATAGI \u0111\u00e3 c\u00f4ng b\u1ed1 c\u00e1c khuy\u1ebfn ngh\u1ecb v\u1ec1 vi\u1ec7c ti\u00eam v\u1eafc-xin COVID-19, Comirnaty\u2122 v\u00e0 COVID-19 AstraZeneca cho b\u1ec7nh nh\u00e2n b\u1ecb suy gi\u1ea3m mi\u1ec5n d\u1ecbch.<\/p>\n<p>T\u1ea5t c\u1ea3 nh\u1eefng ng\u01b0\u1eddi b\u1ecb suy gi\u1ea3m mi\u1ec5n d\u1ecbch \u0111\u1ec1u \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb ti\u00eam v\u1eafc-xin COVID-19 do t\u0103ng nguy c\u01a1 ph\u00e1t tri\u1ec3n th\u00e0nh b\u1ec7nh n\u1eb7ng n\u1ebfu b\u1ecb nhi\u1ec5m SARS-CoV-2. Vi\u1ec7c s\u1eed d\u1ee5ng v\u1eafc-xin COVID-19 n\u00ean \u0111\u01b0\u1ee3c l\u00ean k\u1ebf ho\u1ea1ch v\u1edbi b\u00e1c s\u0129 chuy\u00ean khoa \u0111i\u1ec1u tr\u1ecb v\u00e0 trong m\u1ed9t s\u1ed1 tr\u01b0\u1eddng h\u1ee3p, th\u1eddi gian c\u1ee7a c\u00e1c li\u1ec7u ph\u00e1p \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c thay \u0111\u1ed5i \u0111\u1ec3 t\u1ed1i \u0111a h\u00f3a ph\u1ea3n \u1ee9ng mi\u1ec5n d\u1ecbch \u0111\u1ed1i v\u1edbi vi\u1ec7c ti\u00eam v\u1eafc-xin. C\u0169ng c\u00f3 th\u1ec3 c\u00e2n nh\u1eafc gi\u1ea3m kho\u1ea3ng c\u00e1ch gi\u1eefa c\u00e1c li\u1ec1u v\u1eafc-xin COVID-19 \u0111\u1ec3 cho ph\u00e9p l\u1eadp k\u1ebf ho\u1ea1ch \u0111i\u1ec1u tr\u1ecb.<\/p>\n<p>\u0110\u1ec3 xem c\u00e1c \u0111\u1ec1 xu\u1ea5t n\u00e0y, vui l\u00f2ng tham kh\u1ea3o<\/p>\n<ul>\n<li><a href=\"https:\/\/www.health.gov.au\/resources\/publications\/atagi-provider-guide-to-covid-19-vaccination-of-people-with-immunocompromise\" target=\"_blank\" rel=\"noopener\">ATAGI \u2013 H\u01b0\u1edbng d\u1eabn c\u1ee7a nh\u00e0 cung c\u1ea5p d\u1ecbch v\u1ee5 ti\u00eam ph\u00f2ng COVID-19 cho ng\u01b0\u1eddi b\u1ecb suy gi\u1ea3m mi\u1ec5n d\u1ecbch<\/a><\/li>\n<li><a href=\"https:\/\/www.health.gov.au\/resources\/publications\/atagi-covid-19-vaccination-decision-guide-for-people-with-immunocompromise\" target=\"_blank\" rel=\"noopener\">ATAGI \u2013 H\u01b0\u1edbng d\u1eabn quy\u1ebft \u0111\u1ecbnh ti\u00eam ph\u00f2ng COVID-19 cho ng\u01b0\u1eddi b\u1ecb suy gi\u1ea3m mi\u1ec5n d\u1ecbch<\/a><\/li>\n<\/ul>\n<p>\u0110\u1ec3 bi\u1ebft th\u00f4ng tin kh\u00e1c v\u1ec1 ti\u00eam ch\u1ee7ng cho nh\u1eefng ng\u01b0\u1eddi b\u1ecb suy gi\u1ea3m mi\u1ec5n d\u1ecbch, vui l\u00f2ng tham kh\u1ea3o:<\/p>\n<p><a href=\"https:\/\/mvec.mcri.edu.au\/references\/immunosuppression-and-vaccines\/\">MVEC: Thu\u1ed1c \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch v\u00e0 v\u1eafc-xin<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>T\u1ea5t c\u1ea3 nh\u1eefng ng\u01b0\u1eddi b\u1ecb suy gi\u1ea3m mi\u1ec5n d\u1ecbch \u0111\u1ec1u \u0111\u01b0\u1ee3c khuy\u1ebfn ngh\u1ecb ti\u00eam v\u1eafc-xin COVID-19 do t\u0103ng nguy c\u01a1 ph\u00e1t tri\u1ec3n th\u00e0nh b\u1ec7nh n\u1eb7ng n\u1ebfu b\u1ecb nhi\u1ec5m SARS-CoV-2. Vi\u1ec7c s\u1eed d\u1ee5ng v\u1eafc-xin COVID-19 n\u00ean \u0111\u01b0\u1ee3c l\u00ean k\u1ebf ho\u1ea1ch v\u1edbi b\u00e1c s\u0129 chuy\u00ean khoa \u0111i\u1ec1u tr\u1ecb v\u00e0 trong m\u1ed9t s\u1ed1 tr\u01b0\u1eddng h\u1ee3p, th\u1eddi gian c\u1ee7a c\u00e1c li\u1ec7u ph\u00e1p \u1ee9c ch\u1ebf mi\u1ec5n d\u1ecbch c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c thay \u0111\u1ed5i \u0111\u1ec3 t\u1ed1i \u0111a h\u00f3a ph\u1ea3n \u1ee9ng mi\u1ec5n d\u1ecbch \u0111\u1ed1i v\u1edbi vi\u1ec7c ti\u00eam v\u1eafc-xin. C\u0169ng c\u00f3 th\u1ec3 c\u00e2n nh\u1eafc gi\u1ea3m kho\u1ea3ng c\u00e1ch gi\u1eefa c\u00e1c li\u1ec1u v\u1eafc-xin COVID-19 \u0111\u1ec3 cho ph\u00e9p l\u1eadp k\u1ebf ho\u1ea1ch \u0111i\u1ec1u tr\u1ecb.<\/p>","protected":false},"author":375,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,8,10,61],"tags":[],"class_list":["post-8414","post","type-post","status-publish","format-standard","hentry","category-news","category-covid-19","category-external","category-immunisation-references"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"COVID-19 vaccination is recommended for all immunocompromised people due to an increased risk of developing severe disease if infected with SARS-CoV-2. Administration of COVID-19 vaccines should be planned with the treating specialist and in some instances the timing of immune suppressive therapies may be altered to maximise immune responses to vaccination. Reducing the interval between COVID-19 vaccine doses to allow for planning of treatments can also be considered.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/vi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-30T00:07:59+00:00\" \/>\n<meta name=\"author\" content=\"Rachael McGuire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rachael McGuire\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\"},\"author\":{\"name\":\"Rachael McGuire\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\"},\"headline\":\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise\",\"datePublished\":\"2021-03-30T00:07:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\"},\"wordCount\":137,\"commentCount\":0,\"articleSection\":[\"Show all\",\"COVID-19\",\"External News\",\"Immunisation References\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\",\"name\":\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2021-03-30T00:07:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\",\"name\":\"Rachael McGuire\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/vi\\\/author\\\/rachael-mcguire\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","og_locale":"vi_VN","og_type":"article","og_title":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)","og_description":"COVID-19 vaccination is recommended for all immunocompromised people due to an increased risk of developing severe disease if infected with SARS-CoV-2. Administration of COVID-19 vaccines should be planned with the treating specialist and in some instances the timing of immune suppressive therapies may be altered to maximise immune responses to vaccination. Reducing the interval between COVID-19 vaccine doses to allow for planning of treatments can also be considered.","og_url":"https:\/\/mvec.mcri.edu.au\/vi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2021-03-30T00:07:59+00:00","author":"Rachael McGuire","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Rachael McGuire","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"1 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/"},"author":{"name":"Rachael McGuire","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7"},"headline":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise","datePublished":"2021-03-30T00:07:59+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/"},"wordCount":137,"commentCount":0,"articleSection":["Show all","COVID-19","External News","Immunisation References"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","name":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2021-03-30T00:07:59+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"Trung t\u00e2m gi\u00e1o d\u1ee5c v\u1eafc xin Melbourne (MVEC)","description":"T\u00ecm t\u1ea5t c\u1ea3 c\u00e1c th\u00f4ng tin li\u00ean quan \u0111\u1ebfn v\u1eafc-xin c\u1ee7a b\u1ea1n \u1edf \u0111\u00e2y.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7","name":"Rachel McGuire","url":"https:\/\/mvec.mcri.edu.au\/vi\/author\/rachael-mcguire\/"}]}},"modified_by":"Rachael McGuire","_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/8414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/users\/375"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/comments?post=8414"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/posts\/8414\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/media?parent=8414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/categories?post=8414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/vi\/wp-json\/wp\/v2\/tags?post=8414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}